Chronic obstructive pulmonary disease as a systemic disease: An epidemiological perspective

European Respiratory Journal, Supplement

Volumn 22, Issue 46, 2003, Pages

  Andreassen, H ^a   Vestbo, J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Body mass index; Chronic obstructive pulmonary disease; Epidemiology; Muscle dysfunction; Weight loss

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; CARBON MONOXIDE; CYTOKINE; FIBRINOGEN; HYDROGEN PEROXIDE; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE; NITROGEN OXIDE; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER;

BODY COMPOSITION; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MUSCLE DISEASE; OSTEOPOROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING; WASTING SYNDROME; WEIGHT REDUCTION; PATHOLOGY; PATHOPHYSIOLOGY;

BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 1542389120     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. World Health Organization. The GOLD global strategy for the management and prevention of COPD. www.goldcopd. com. Date accessed: September 2002.
2. Wouters EFM, Creutzberg EC, Schols AMWJ. Systemic effects in COPD. Chest 2002; 121: 127s-130s.
3. Gross NJ. Extrapulmonary effects of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2001; 7: 84-92.
4. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radical Biology and Med 1996; 21: 669-681.
5. MacNee W. Oxidants/antioxidants and COPD. Chest 2000; 117: 303s-317s.
6. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1993; 128: 833-838.
7. Confalonieri M, Mainardi EM, Della Porta R, et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53: 583-585.
8. Stanescu D, Sanna A, Veriter C, et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271.
9. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155: 449-453.
10. Chan-Yeung M, Abboud R, Buncio AD, Vedal S. Peripheral leukocyte count and longitudinal decline in lung function. Thorax 1988; 43: 462-466.
11. Dentener MA, Creuzberg EC, Schols AMWJ, et al. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax 2001; 56: 721-726.
12. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
13. Yasuda N, Gotoh K, Minatoguchi S, et al. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 1998; 92: 993-999.
14. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute excercabations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fubrinogen and serum IL-6 levels. Thromb Haemost 2000; 84: 210-215.
15. Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-1623.
16. Dahl M, Tybjærg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 164: 1008-1011.
17. Schwaiblmair M, Vogelmeier C, Fruhmann G. Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency - three year follow up. Respiration 1997; 64: 10-15.
18. Welle I, Bakke PS, Eide GE, Fagerhol MK, Omenaas E, Gulsvik A. Increased circulating levels of alpha1-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs. Ear Respir J 2001; 17: 1105-1111.
19. Casaburi R. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Med Sci Sports Excerc 2001; 33: S662-S670.
20. Biskobing DM. COPD and osteoporosis. Chest 2002; 12: 609-620.
21. Walsch LJ, Lewis SA, Wong CA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 2002; 166: 691-695.
22. Schols AMWJ, Soeters AMC, Dingemans R, Mostert PJ, Frantzen, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am J Respir Crit Care Med 1993; 147: 1151-1156.
23. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 809-813.
24. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455.
25. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996; 153: 633-637.
26. Takabatake N, Nakamura H, Abe S, et al. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1215-1219.
27. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-1438.
28. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
29. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 961-966.
30. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861.
31. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-544.